Literature DB >> 16352915

The uremic environment and muscle dysfunction in man and rat.

A P Harrison1, A H Nielsen, I Eidemak, S Molsted, E M Bartels.   

Abstract

BACKGROUND: Patients reaching end-stage renal disease experience debilitating fatigue, with progression of this disease, rendering patients dysfunctional in their everyday lives.
METHODS: In vivo measurements of muscle function, assessed using surface electromyography (EMG), were made on 25 patients prior to and after a session of hemodialysis (HD) treatment, along side in vitro measurements of muscle function in isolated rat muscles incubated in normal or uremic conditions approximating to those found in uremic rats (rat uremic: RU) or uremic humans (human uremic: HU).
RESULTS: HD significantly affected plasma values, e.g. reducing urea (69%), creatinine (62%), potassium (23%) and phosphate (48%) concentrations in patients (all p < 0.01). Treatment also improved the EMG frequency of 2nd dorsal interosseous (fast-twitch) (p < 0.01), although no change was noted for vastus lateralis (slow-twitch). In isolated rat muscles, a uremic environment had no significant effect on slow-twitch soleus during field stimulation, however, in fast-twitch extensor digitorum longus, a significant 23% (RU) and 22% (HU) faster rate of decline in force was measured, compared to controls (p < 0.001 and p < 0.01, respectively).
CONCLUSION: It is concluded that (1) muscle weakness and its electrophysiological correlates may be rapidly induced by uremic solutes and rapidly reversed when the solutes are removed by dialysis, and (2) fast-twitch muscles are more readily affected by uremic conditions than slow-twitch muscles. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16352915     DOI: 10.1159/000090221

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  8 in total

Review 1.  Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review.

Authors:  Anuradha Sawant; S Jayne Garland; Andrew A House; Tom J Overend
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

Review 2.  Non-crystalline and crystalline rheumatic disorders in chronic kidney disease.

Authors:  Pasha Sarraf; Jonathan Kay; Anthony M Reginato
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

3.  Natural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational study.

Authors:  Stephen G John; Mhairi K Sigrist; Maarten W Taal; Christopher W McIntyre
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice.

Authors:  Kyoungrae Kim; Erik M Anderson; Trace Thome; Guanyi Lu; Zachary R Salyers; Tomas A Cort; Kerri A O'Malley; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-14

5.  Muscle contraction and force: the importance of an ancillary network, nutrient supply and waste removal.

Authors:  Dagmar A Brüggemann; Jens Risbo; Stefan G Pierzynowski; Adrian P Harrison
Journal:  Int J Mol Sci       Date:  2008-08-20       Impact factor: 6.208

6.  Portable acoustic myography - a realistic noninvasive method for assessment of muscle activity and coordination in human subjects in most home and sports settings.

Authors:  Adrian P Harrison; Bente Danneskiold-Samsøe; Else M Bartels
Journal:  Physiol Rep       Date:  2013-07-10

7.  The relation between maximal voluntary force in m. palmaris longus and the temporal and spatial summation of muscle fiber recruitment in human subjects.

Authors:  Cécyl G Claudel; Waqas Ahmed; Vibeke S Elbrønd; Adrian P Harrison; Else Marie Bartels
Journal:  Physiol Rep       Date:  2018-01

8.  A Systematic Review of the Acute Effects of Hemodialysis on Skeletal Muscle Perfusion, Metabolism, and Function.

Authors:  Shatha J Almushayt; Samia Hussain; Daniel J Wilkinson; Nicholas M Selby
Journal:  Kidney Int Rep       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.